MIT 90% Mitragynine Extract Powder package and powder scoop on a clean white background

Looking for a “Legal 7-OH Alternative”? Compare MIT Product Identity

August 26, 2026 at 10:38 am

Federal checkpoint: August 26, 2026.

The phrase “legal 7-OH alternative” suggests a simple replacement, but it collapses product identity and jurisdiction. Mitragynine-focused tablets and extract powder are different product formats built around MIT, kratom's principal alkaloid. The August 26 federal order placed mitragynine pseudoindoxyl (MGPI), MGM-15, and MGM-16 in Schedule I; it did not place mitragynine itself in Schedule I. That distinction does not make any MIT product legal everywhere, FDA approved, or equivalent to 7-OH.

For an adult shopper in an eligible destination, the most practical current comparison is between 150mg MIT Mango chewable tablets and MIT 90% Mitragynine Extract Powder. Tablets offer a count-based package. Powder offers a weight-based package. The better fit depends on the format, current documentation, storage needs, quantity, and destination rules—not on a promised 7-OH effect.

The short answer: compare identity before choosing an alternative

Four identities that should remain separate
Identity	Current federal point	Useful shopping distinction
7-hydroxymitragynine above a proposed threshold	DEA began a temporary-scheduling process; HHS extended comments about the proposed threshold through September 10, 2026	Concentrated 7-OH is not interchangeable with an MIT-labeled product
MGPI, MGM-15, and MGM-16	Temporarily placed in Schedule I effective August 26, 2026	These three compounds are separate from mitragynine
150mg MIT Mango tablets	The August 26 order did not place mitragynine itself in Schedule I	Pressed, chewable, count-based format with a finished-tablet report for identified lot M/150/002
MIT 90% extract powder	The August 26 order did not place mitragynine itself in Schedule I	Loose, unflavored, weight-based format with a concentrate report for identified sample DD00126B(15)

Federal controlled-substance status is only one layer. FDA separately states that kratom and its alkaloids are not lawfully marketed as drugs, dietary supplements, or conventional-food additives. States and localities can also impose their own restrictions. Check the Kratom Legality & Shipping Restrictions page and the actual destination before ordering.

Why MIT is a logical comparison—but not a 7-OH substitute

Mitragynine and 7-OH both interact with human mu-opioid receptors, but their pharmacology and potency differ. Repeated use of concentrated kratom-related products can involve tolerance, dependence, and withdrawal. Changing the label from 7-OH to MIT does not remove those risks.

No reliable milligram-for-milligram conversion connects a 7-OH product to an MIT tablet or a quantity of extract powder. Product formulation, analytical results, absorption, individual response, and prior use all matter. Anyone dealing with severe withdrawal, uncontrolled use, marked sedation, breathing problems, or another urgent reaction should seek qualified medical help rather than rely on a product-switching chart.

For the calculation issue in detail, read Can You Convert 7-OH Milligrams to MIT?

MIT tablets: the count-based option

The current Kratom Paradise tablet line is 150mg MIT Mango. Standard packages contain 5, 10, 25, 50, 100, or 250 tablets; bulk packages contain 500, 1,000, or 5,000 tablets. The practical advantages are physical: a dry pressed format, a countable inventory, and packaging that is easier to reconcile by unit than loose powder.

The linked Cora Science report identifies pressed Mitragynine Tablet lot M/150/002, issued September 19, 2025. It reports 146mg mitragynine per unit, 0.148mg 7-hydroxymitragynine per unit, and 153mg total Mitragyna alkaloids per unit. The report identifies the tested lot and matrix; it does not identify Mango flavor or establish every future lot.

Use the MIT Chewable Tablets collection to compare live counts and prices, then match the selected item to the MIT Product Documents & COA Center.

MIT 90% powder: the weight-based option

The current powder line is MIT 90% Mitragynine Extract Powder, sold unflavored by net weight. Standard options run from 0.5g through 25g; bulk options run from 50g through 1kg. Powder provides more weight tiers and lower listed cost per gram at larger sizes, while requiring careful storage and a clear package record.

The linked PharmLabs San Diego report identifies submitted concentrate sample DD00126B(15), sample ID SD260715-011 (142956), reported July 20, 2026. It lists 87.01% mitragynine (870.12mg/g) and 9.08% speciociliatine (90.79mg/g). The 90% wording is the product-line name; 87.01% is the measured mitragynine result for that sample.

The same report lists 7-OH and MGM-15 as not detected under its stated method and reporting limits. “Not detected” is a sample-specific laboratory result, not a universal zero claim or legal certification. Compare live weight tiers at MIT Extract Powder.

Which format fits which priority?

Choose the tablet lane to compare counts: package decisions and price math stay per tablet.
Choose the powder lane to compare weights: package decisions and price math stay per gram.
Choose by document scope: the tablet report covers an identified finished-tablet lot; the powder report covers an identified concentrate sample.
Choose by handling: tablets are countable; loose powder requires dry storage and weight-based inventory.
Choose by destination: availability on a webpage is not permission to ship or possess an item in every jurisdiction.

The MIT Tablets vs MIT Extract Powder comparison puts the current selectors, report units, and package economics side by side.

What “best legal alternative” can honestly mean

There is no federally endorsed or clinically established “best” alternative to 7-OH. Current Kratom Paradise tablets and MIT 90% powder can be compared only as mitragynine formats—count-based versus weight-based—with separate label and COA scope. Neither should be presented as a pharmacological replacement, a medical use for withdrawal, a safer equivalent, or a guarantee of legality.

Before checkout, confirm the complete title, selected count or weight, current price, destination, report identity, and report scope. Recheck the dated federal tracker because a notice, comment period, temporary order, enforcement policy, and state rule are different kinds of authority.

Compare current MIT product formats

Check the current MIT product records

Open the 150mg-label Mango MIT tablet listing or the MIT 90% extract-powder listing for current package choices, price, availability, and report links. Product identity and destination eligibility still need to be checked at the time of purchase.